TrialJAMA oncology2020

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.

Paul J Bröckelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.